An Article in support of SDGs 2 and 3, analysing the effectiveness of multiple micronutrient powders in infants and showing net health benefits of this intervention in most countries, although cost-effectiveness varied in different settings.
Elsevier,

Diagnosis and Management in Dementia, Volume 1, August 2020, Pages 3-15

This book chapter advances SDGs 3 and 17 by reviewing how to diagnosis mixed dementias.
This book chapter advances SDG 3 and 10 by reviewing the literature on culture and family-based psychological interventions for schizophrenia, bipolar, and related (SBR) psychotic spectrum disorder.
Elsevier,

Diagnosis and Management in Dementia, Volume 1, August 2020, Pages 127-146

This book chapter advances SDGs 3 and 17 by focusing on providing a brief overview of genes associated with sporadic (late-onset) Alzheimer's disease (AD). Despite decades of research, no current and reliable test is currently available for the diagnosis of AD. Genetic biomarkers are promising for both diagnostic tools and tailored profiling therapy.
This book chapter advances SDGs 3 and 17 by discussing available data regarding the effects of genetic variants on the clinical and pathological characteristics of “frontotemporal dementia” (FTD). The term “frontotemporal dementia” (FTD) defines a group of related diseases resulting from progressive degeneration of the temporal and frontal lobes. These areas play a significant role in decision-making, behavioral control, emotion, language, and motor functions.
Elsevier,

Diagnosis and Management in Dementia, Volume 1, August 2020, Pages 665-680

This book chapter advances SDGs 3 and 17 by describing how acute hospital settings can affect the care of patients with dementia. As well as changes to the physical hospital environment, this requires an enhanced focus on key strategies such as reliable identification of cognitive impairment, access to comprehensive geriatric assessment, prevention and management of delirium, and timely discharge planning are included in the chapter.
This book chapter advances SDGs 3 and 17 by reviewing pathological and functional outcomes of both preventative and therapeutic environmental enrichment on commonly used mouse models of amyloid pathology.
Elsevier,

Diagnosis and Management in Dementia, Volume 1, August 2020, Pages 827-842

This book chapter advances SDGs 3 and 17 by discussing the potential impact of dementia on creativity, physical activity, and exercise participation and whether exercise and creativity may each exert individual effects on the maintenance and/or facilitation of cognitive health. This chapter explores the context of biological and theoretical mechanisms underlying dementia and provide recommendations for future research experiments unifying physical exercise and creative activities into tailored interventions designed to better comprehend this disease and perhaps counteract the devastating implications dementia prognoses present to optimal physical and mental functioning across the human life span.
The SDG Impact of COVID-19 podcast series gathers expert opinion exploring the impact of COVID-19 on the Sustainable Development Goals. In this segment, we get the view of Joan Walley, Chair of the Aldersgate Group and former Labour MP.
This Research Paper supports SDG 3 by demonstrating that the use of rapid whole-exome sequencing to detect rare genetic diseases can reduce health-care expenditure and achieve net healthcare cost-savings in clinical settings in Hong Kong.

Pages